|
Contact info: (415) 962-2552 karl(at)cmea(dot)com |
Executive Assistant Contact info: Leslie Loven (415) 901-0628 leslie(at)cmea(dot)com |
Joined CMEA: 1999
Years Experience Building Companies: 18
Education: Graduate Degrees, MIT and Harvard Medical School
Board Seats: Ensemble Discovery (Observer), Intellikine, Phenomix ( Observer), Tetraphase
Deal Starters: Novel therapeutics with a direct financial and clinical path
Non-starters: Extraordinary claims without supporting data
Outside Activities: Solar astronomy and synthetic biology
You have to believe Karl Handelsman is fully immersed in science when the Managing Director of CMEA’s Life Sciences division listed solar astronomy and synthetic biology as his favorite pastimes. The 11-year CMEA veteran has a passion for science and innovation .
Karl has been privileged to work alongside talented entrepreneurs. The management teams at Ambrx, Ensemble Discovery, Ilypsa, Intellikine, Kalypsys, Maxygen, Phenomix, Rigel, Syrrx, Tetraphase, and Xenoport – all have contributed to Karl’s wealth of experience executing visionary plans.
Prior to joining CMEA, Karl worked in biotech business development at Millennium. He was one of the first employees of Tularik, and the Whitehead Institute.